Immunohistochemical Expression of Wnt-4 Protein in Clear Cell Renal Carcinoma

被引:2
作者
Pavlovic, Oliver [1 ,2 ]
Hudolin, Tvrtko [3 ,4 ]
Miskulin, Ivan [5 ]
Bulimbasic, Stela [4 ,6 ]
Coric, Marijana [4 ,6 ]
Perkovic, Josip [1 ,2 ]
Zekulic, Toni [3 ]
机构
[1] Univ Hosp Ctr Osijek, Dept Urol, Osijek 31000, Croatia
[2] Josip Juraj Strossmayer Univ Osijek, Dept Surg Urol Orthoped & Phys & Rehabil Med, Fac Med Osijek, Osijek 31000, Croatia
[3] Univ Hosp Ctr Zagreb, Dept Urol, Zagreb 10000, Croatia
[4] Univ Zagreb, Zagreb Sch Med, Zagreb 10000, Croatia
[5] Josip Juraj Strossmayer Univ Osijek, Fac Med Osijek, Dept Publ Hlth, Osijek 31000, Croatia
[6] Univ Hosp Ctr Zagreb, Dept Pathol & Cytol, Zagreb 10000, Croatia
关键词
clear cell renal carcinoma; Wnt signaling pathway; Wnt-4; protein; immunohistochemistry;
D O I
10.3390/jcm10245795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Wingless binding integration site proteins (Wnt) have an important role in normal kidney development and in various kidney diseases. They are required for complete epithelial differentiation and normal nephron formation. Changes in these proteins could also have important role in carcinogenesis. This study included 185 patients with clear cell renal carcinoma (ccRCC) in whom immunohistochemical expression of Wnt-4 protein in healthy and tumorous tissue after surgery was investigated. There was higher expression of Wnt-4 in healthy than in tumor tissue. No difference between Fuhrman's grade and Wnt-4 expression was found. A poor negative correlation between tumor size and Wnt-4 expression was found. Patients with suspected metastatic diseases had higher Wnt-4 expression. There was no difference in survival rates between Wnt-4 negative and positive groups. In our study we have shown that high Wnt-4 expression in healthy tissue decreases in low-grade tumors but then increases in high-grade tumors, suggesting that tumor progression requires Wnt-4 activation or reactivation.
引用
收藏
页数:9
相关论文
共 28 条
[1]   Renal cell carcinoma [J].
Cairns, Paul .
CANCER BIOMARKERS, 2011, 9 (1-6) :461-473
[2]   Renal cancer [J].
Capitanio, Umberto ;
Montorsi, Francesco .
LANCET, 2016, 387 (10021) :894-906
[3]   Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].
Ferlay, J. ;
Steliarova-Foucher, E. ;
Lortet-Tieulent, J. ;
Rosso, S. ;
Coebergh, J. W. W. ;
Comber, H. ;
Forman, D. ;
Bray, F. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403
[4]   Wnt Signaling in Cancer: Not a Binary ON:OFF Switch [J].
Flanagan, Dustin J. ;
Vincan, Elizabeth ;
Phesse, Toby J. .
CANCER RESEARCH, 2019, 79 (23) :5901-5906
[5]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[6]   Recent updates on Wnt signaling modulators: a patent review (2014-2020) [J].
Goswami, Vishalgiri G. ;
Patel, Bhumika D. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (11) :1009-1043
[7]   Wnt signaling mediates new nephron formation during zebrafish kidney regeneration [J].
Kamei, Caramai N. ;
Gallegos, Thomas F. ;
Liu, Yan ;
Hukriede, Neil ;
Drummond, Iain A. .
DEVELOPMENT, 2019, 146 (08)
[8]   Impaired Wnt-β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy [J].
Lancaster, Madeline A. ;
Louie, Carrie M. ;
Silhavy, Jennifer L. ;
Sintasath, Louis ;
DeCambre, Marvalyn ;
Nigam, Sanjay K. ;
Willert, Karl ;
Gleeson, Joseph G. .
NATURE MEDICINE, 2009, 15 (09) :1046-U101
[9]   The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications [J].
Linehan, W. Marston ;
Ricketts, Christopher J. .
NATURE REVIEWS UROLOGY, 2019, 16 (09) :539-552
[10]   Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway [J].
Liu, Fei ;
Li, Wei ;
Hua, Shangbo ;
Han, Ye ;
Xu, Zhihua ;
Wan, Daiwei ;
Wang, Yilin ;
Chen, Weichang ;
Kuang, Yuting ;
Shi, Jianming ;
Zhi, Qiaoming .
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (05) :952-965